Please Wait.....
Report
North America Ophthalmic Drugs And Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 117 Pages I Mordor Intelligence
North America Ophthalmic Drugs And Devices Market Analysis
The North America ophthalmology market stands at USD 39.34 billion in 2025 and is forecast to post USD 51.35 billion by 2030, advancing at a 4.7% CAGR. Growth has moderated from the last decade's surge, yet the sector keeps expanding because almost three-quarters of severe vision loss could still be prevented through early detection and timely care. The demographic tilt toward an older population underpins a steady flow of cataract, glaucoma, and diabetic eye-disease cases, while private-equity backed consolidation is reshaping competitive dynamics to secure scale and technology leverage. Practice profitability faces short-term pressure after Medicare trimmed physician reimbursement by 2.8% in 2025, nudging providers toward higher-margin premium intraocular lenses (IOLs), minimally invasive surgery, and continuous-delivery drug implants. Rural under-supply is projected to leave 30% of ophthalmology positions unfilled by 2035, which has accelerated optometric scope expansion and fueled the adoption of AI-powered tele-ophthalmology platforms that bring diagnostics to underserved communities. Despite these headwinds, the North American ophthalmology market retains a reputation for recession-resilient demand because most conditions impair daily living if care is delayed.
North America Ophthalmic Drugs And Devices Market Trends and Insights
Aging Population Accelerating Prevalence of Chronic Ophthalmic Conditions
People aged 65 and above are growing 3.2% per year across North America, and vision quality declines sharply once individuals cross the mid-50s threshold. Nearly 750,000 Americans already live with diabetic macular edema, reinforcing demand for long-term disease management solutions. The demographic shift keeps ophthalmology clinics busy even during economic slowdowns because untreated cataract, glaucoma, and retinal disorders quickly erode functional independence. Older adults also show a higher readiness to pay for premium IOLs that restore spectacle-free vision, supporting upsell opportunities. Workforce shortages in rural counties intensify the need for tele-screening and optometric co-management, aligning with recent scope expansions authorized in several US states.
Technological Breakthroughs in Minimally Invasive & Image-Guided Eye Surgery
Advances in femtosecond lasers, robotic guidance, and real-time optical coherence tomography are trimming surgery time and reducing operator variability. Alcon's Voyager Direct SLT device, for instance, eliminates manual aiming and the need for a gonio lens while treating nearly 5 million Americans living with glaucoma. FDA breakthrough-device approvals (e.g., FYXS Ocular Pressure Adjusting Pump) signal the regulator's commitment to the rapid diffusion of meaningful innovation. Ambulatory surgery centers, which received a 2.8% reimbursement bump for quality reporting in 2025, are quick adopters because shorter procedures boost throughput. As these platforms cost well above USD 350,000, capital expenditure favors multisite groups, deepening practice consolidation trends.
High Cost of Advanced Devices & Limited Procedure Reimbursement
Medicare's 2025 conversion-factor cut to USD 32.35 pushed cataract fees down to USD 521.75, barely covering the disposable pack cost when expensive femtosecond lasers are used. Provincial Canadian plans still reimburse only manual phacoemulsification with monofocal lenses, leaving premium IOLs entirely patient-paid. Small practices hesitate to finance USD 500,000 surgical platforms without a clear volume pipeline, so technology diffusion skews toward corporate groups and academic centers. A nascent trend toward office-based surgery could trim facility fees, yet Medicare has not differentiated payments by site of service, limiting near-term relief.
Other drivers and restraints analyzed in the detailed report include:
Rising Adoption of Premium IOLs & Femtosecond Laser-Assisted Cataract Procedures / AI-Powered Tele-Ophthalmology Expanding Rural Access / Specialty Optical-Component Supply Bottlenecks /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Devices accounted for 60.3% of 2024 revenue in the North America ophthalmology market, reflecting the capital nature of surgical platforms and diagnostic imaging. Drugs, however, are set to log the fastest 9.6% CAGR and are projected to lift their slice of the North America ophthalmology market size alongside launches such as Alcon's TRPM8 agonist Tryptyr for dry eye and Genentech's refillable Susvimo implant for retinal disorders. Premium cataract systems, femtosecond lasers and next-generation ultrasound phaco machines allow clinics to charge higher facility fees, keeping equipment demand healthy. Diagnostic-device makers integrate AI algorithms into optical coherence tomography to automate pathology flagging, further supporting hardware upgrades.
Pharmaceutical innovators target chronic care. Susvimo delivers ranibizumab continuously, cutting injections from 12 to two per year and boosting adherence. Generic pressure weighs on first-generation anti-VEGF agents, but biologics coupled with depot implants blur the once-clear boundary between "device" and "drug", prompting new reimbursement codes. Vision-care accessories-traditional contact lenses and consumer sunglasses-see margin dilution due to online retailers that bypass optician channels. Overall, devices will keep the larger pool, but drugs will account for most incremental growth through 2030.
The North America Ophthalmic Drugs and Devices Market Ris Segmented by Product (Devices {Surgical Devices, Diagnostic Devices, and More} and Drugs {Glaucoma Drugs, Retinal Disorder Drugs, and More), Disease (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and More), and Geography (United States, Canada, Mexico). The Market Sizes and Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Alcon / Bausch + Lomb / Carl Zeiss / EssilorLuxottica / HAAG-Streit / Johnson&Johnson / Nidek / Topcon / Ziemer Group / AbbVie (Allergan Eye Care) / Novartis / Roche (Genentech) / Santen Pharmaceutical Co. / The Cooper Companies / Glaukos / STAAR Surgical / Lumenis / Aerie Pharmaceutical / Boston Scientific (ELLEX assets) / Visioneering Technologies Inc. /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Aging Population Accelerating Prevalence of Chronic Ophthalmic Conditions
4.2.2 Technological Breakthroughs in Minimally Invasive & Image-Guided Eye Surgery
4.2.3 Rising Adoption of Premium IOLs & Femtosecond Laser-Assisted Cataract Procedures
4.2.4 AI-Powered Tele-Ophthalmology Expanding Rural Access
4.2.5 Corporate Vision-Benefit Programs Boosting Routine Eye-Care Demand
4.2.6 FDA Breakthrough Device Pathway Speeding Novel Ocular Technologies
4.3 Market Restraints
4.3.1 High Cost of Advanced Devices & Limited Procedure Reimbursement
4.3.2 Stringent Approval Pathway for Combination Drug-Device Products
4.3.3 Specialty Optical-Component Supply Bottlenecks
4.3.4 Generic Drug Competition Compressing Branded-Drug Pricing
4.4 Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Product
5.1.1 Devices
5.1.1.1 Surgical Devices
5.1.1.1.1 Intra-ocular Lenses
5.1.1.1.2 Ophthalmic Lasers
5.1.1.1.3 Phacoemulsification Systems
5.1.1.1.4 Other Surgical Devices
5.1.1.2 Diagnostic Devices
5.1.1.2.1 Optical Coherence Tomography Scanners
5.1.1.2.2 Fundus Cameras
5.1.1.2.3 Tonometers
5.1.1.2.4 Other Diagnostic Devices
5.1.1.3 Vision Care Devices
5.1.1.3.1 Contact Lenses
5.1.1.3.2 Spectacle Lenses
5.1.2 Drugs
5.1.2.1 Glaucoma Drugs
5.1.2.2 Retinal Disorder Drugs
5.1.2.3 Dry-Eye Therapies
5.1.2.4 Anti-Allergy / Anti-Inflammatory Drugs
5.1.2.5 Anti-Infective Drugs
5.1.2.6 Other Drugs
5.2 By Disease
5.2.1 Glaucoma
5.2.2 Cataract
5.2.3 Age-related Macular Degeneration
5.2.4 Diabetic Retinopathy
5.2.5 Inflammatory Diseases
5.2.6 Refractive Disorders
5.2.7 Other Diseases
5.3 By End User
5.3.1 Hospitals
5.3.2 Specialty Clinics & ASCs
5.3.3 Retail Pharmacies & Optical Stores
5.3.4 Online Pharmacies
5.4 By Country
5.4.1 United States
5.4.2 Canada
5.4.3 Mexico
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, Recent Developments)
6.3.1 Alcon Inc.
6.3.2 Bausch + Lomb
6.3.3 Carl Zeiss Meditec AG
6.3.4 EssilorLuxottica SA
6.3.5 Haag-Streit Group
6.3.6 Johnson & Johnson Vision
6.3.7 Nidek Co., Ltd.
6.3.8 Topcon Corporation
6.3.9 Ziemer Group AG
6.3.10 AbbVie (Allergan Eye Care)
6.3.11 Novartis AG
6.3.12 Roche (Genentech)
6.3.13 Santen Pharmaceutical Co.
6.3.14 CooperVision
6.3.15 Glaukos Corporation
6.3.16 STAAR Surgical Company
6.3.17 Lumenis
6.3.18 Aerie Pharmaceuticals
6.3.19 Boston Scientific (ELLEX assets)
6.3.20 Visioneering Technologies Inc.
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security